skip to main content
Refinado por: assunto: Medical Sciences remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study

Al-Sarraf, M ; Metch, B ; Kish, J ; Ensley, J ; Rinehart, J J ; Schuller, D E ; Coltman, Jr, C A

Cancer treatment reports, 1987-07, Vol.71 (7-8), p.723

United States

Sem texto completo

2
Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas : a Southwest Oncology Group Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas : a Southwest Oncology Group Study

BUDD, G. T ; METCH, B ; WEISS, S. A. W ; WEICK, J. K ; FABIAN, C ; STEPHENS, R. L ; BALCERZAK, S.P

Cancer chemotherapy and pharmacology, 1993, Vol.31, p.S213-S216 [Periódico revisado por pares]

Berlin: Springer

Texto completo disponível

3
High‐dose cisplatin for metastatic soft tissue sarcoma
Material Type:
Artigo
Adicionar ao Meu Espaço

High‐dose cisplatin for metastatic soft tissue sarcoma

Budd, G. Thomas ; Metch, Barbara ; Balcerzak, Stanley P. ; Fletcher, William S. ; Baker, Laurence H. ; Mortimer, Joanne E.

Cancer, 1990-02, Vol.65 (4), p.866-869 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

4
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease : a summary of the southwest oncology group experience
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease : a summary of the southwest oncology group experience

HERSH, E. M ; METCH, B. S ; MUGGIA, F. M ; BROWN, T. D ; WHITEHEAD, R. P ; BUDD, G. T ; RINEHART, J. J ; CRAWFORD, E. D ; BONNET, J. D ; BEHRENS, B. C

Journal of immunotherapy, 1991-12, Vol.10 (6), p.426-431 [Periódico revisado por pares]

New York, NY: Raven Press

Texto completo disponível

5
Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study

KUEBLER, J. P ; METCH, B ; SCHULLER, D. E ; KEPPEN, M ; HYNES, H. E

Investigational new drugs, 1991-11, Vol.9 (4), p.373-374 [Periódico revisado por pares]

Dordrecht: Kluwer

Texto completo disponível

6
Quality of Life End Points in Cancer Clinical Trials: Review and Recommendations
Material Type:
Artigo
Adicionar ao Meu Espaço

Quality of Life End Points in Cancer Clinical Trials: Review and Recommendations

Moinpour, Carol McMillen ; Feigl, Polly ; Metch, Barbara ; Hayden, Katherine A. ; Meyskens, Frank L. ; Crowley, John

JNCI : Journal of the National Cancer Institute, 1989-04, Vol.81 (7), p.485-496 [Periódico revisado por pares]

Cary, NC: Oxford University Press

Sem texto completo

7
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study
Material Type:
Artigo
Adicionar ao Meu Espaço

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

RAVDIN, PM ; GREEN, S ; DORR, TM ; MCGUIRE, WL ; FABIAN, C ; PUGH, RP ; CARTER, RD ; RIVKIN, SE ; BORST ; BELT, RJ ; METCH, B ; OSBORNE, CK

Journal of clinical oncology, 1992-08, Vol.10 (8), p.1284-1291 [Periódico revisado por pares]

ALEXANDRIA: American Society of Clinical Oncology

Sem texto completo

8
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study
Material Type:
Artigo
Adicionar ao Meu Espaço

One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study

RIVKIN, S. E ; GREEN, S ; METCH, B ; JEWELL, W. R ; COSTANZI, J. J ; ALTMAN, S. J ; MINTON, J. P ; O'BRYAN, R. M ; OSBORNE, C. K

Journal of clinical oncology, 1993-09, Vol.11 (9), p.1710-1716 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

9
Phase II trial of echinomycin in advanced soft tissue sarcomas : a southwest oncology group study
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II trial of echinomycin in advanced soft tissue sarcomas : a southwest oncology group study

TAYLOR, S. A ; METCH, B ; BALCERZAK, S. P ; HANSON, K. H

Investigational new drugs, 1990-11, Vol.8 (4), p.381-383 [Periódico revisado por pares]

Dordrecht: Kluwer

Texto completo disponível

10
Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study

Weiss, G B ; Metch, B ; Von Hoff, D D ; Taylor, S A ; Saiers, J H

Cancer treatment reports, 1987-12, Vol.71 (12), p.1313

United States

Sem texto completo

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (6)
  2. Revistas revisadas por pares (10)

Data de Publicação 

De até
  1. Antes de1987  (1)
  2. 1987Até1988  (2)
  3. 1989Até1989  (1)
  4. 1990Até1991  (5)
  5. Após 1991  (4)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.